Allianz Global Investors Fund - Allianz Europe Equity Growth Select IT (H2-USD)Register to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 14.0 | 36.5 | -16.5 | 17.6 | 6.2 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 03/05/2024 | USD 2043.54 | |
Day Change | -0.67% | |
Morningstar Category™ | Other Equity | |
ISIN | LU1224415551 | |
Fund Size (Mil) 03/05/2024 | EUR 935.97 | |
Share Class Size (Mil) 03/05/2024 | USD 49.92 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 0.96% |
Investment Objective: Allianz Global Investors Fund - Allianz Europe Equity Growth Select IT (H2-USD) |
Long-term capital growth by investing in European equity markets with a focus on growth stocks of large market capitalization companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Giovanni Trombello 12/05/2020 | ||
Andreas Hildebrand 10/10/2023 | ||
Click here to see others | ||
Inception Date 22/05/2015 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P Europe LargeCap Growth NR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Allianz Global Investors Fund - Allianz Europe Equity Growth Select IT (H2-USD) | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
ASML Holding NV | Technology | 9.47 |
Novo Nordisk A/S Class B | Healthcare | 9.30 |
DSV AS | Industrials | 5.30 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 5.03 |
Sika AG | Basic Materials | 4.30 |
Increase Decrease New since last portfolio | ||
Allianz Global Investors Fund - Allianz Europe Equity Growth Select IT (H2-USD) |